10-KPeriod: FY2019

CVS HEALTH Corp Annual Report, Year Ended Dec 31, 2019

Filed February 18, 2020For Securities:CVS

Summary

CVS Health Corporation's (CVS) 2019 10-K filing highlights a year of significant transformation, largely driven by the transformative acquisition of Aetna completed in late 2018. This integration propelled the company's revenue growth by 32.0% to $256.8 billion, fueled by the newly added Health Care Benefits segment which encompasses Aetna's insurance operations. The company continues to focus on its strategy of being a consumer-centric health innovator, aiming to make healthcare more affordable, accessible, simple, and seamless. Financially, the company navigated substantial debt from the Aetna acquisition, reporting total revenues of $256.8 billion for 2019. Operating income saw a significant increase to $11.99 billion, primarily due to the absence of large goodwill impairment charges from the prior year and the impact of the Aetna integration. The company remains committed to its multi-faceted business model encompassing Pharmacy Services, Retail/LTC, and Health Care Benefits, while diligently managing integration costs and debt levels.

Financial Statements
Beta
Revenue$256.78B
Cost of Revenue$158.72B
Gross Profit$98.06B
Operating Expenses$244.79B
Operating Income$11.99B
Interest Expense$3.04B
Net Income$6.63B
EPS (Basic)$5.10
EPS (Diluted)$5.08
Shares Outstanding (Basic)1.30B
Shares Outstanding (Diluted)1.30B

Key Highlights

  • 1Total revenues surged by 32.0% to $256.8 billion in 2019, largely driven by the inclusion of Aetna's operations.
  • 2Operating income increased substantially to $11.99 billion in 2019, up from $4.02 billion in 2018, benefiting from the absence of prior year goodwill impairment charges and the Aetna acquisition.
  • 3The company is actively managing its significant debt load incurred from the Aetna acquisition, which totaled $64.7 billion in long-term debt at the end of 2019.
  • 4The Pharmacy Services segment demonstrated growth, with total revenues increasing by 5.0% to $141.5 billion, supported by increased claims volume and improved purchasing economics.
  • 5The Retail/LTC segment reported a 3.1% revenue increase to $86.6 billion, driven by pharmacy revenue growth and same-store sales, though operating income was impacted by store rationalization charges and the sale of a subsidiary.
  • 6The Health Care Benefits segment, significantly expanded by the Aetna acquisition, saw total revenues jump by 676.7% to $69.6 billion.
  • 7CVS Health is continuing its strategic focus on integrating its pharmacy, retail, and health insurance businesses to create a more comprehensive and consumer-centric healthcare experience.

Frequently Asked Questions

The primary driver of the substantial revenue increase in 2019 was the acquisition of Aetna, which was completed in November 2018. This acquisition significantly expanded CVS Health's Health Care Benefits segment, contributing to a 32.0% overall increase in total revenues to $256.8 billion.

The Aetna acquisition had a mixed impact on profitability. While it significantly boosted revenue and operating income (aided by the absence of prior year goodwill impairment charges), the company also incurred substantial debt to finance the acquisition, leading to increased interest expenses. Integration costs also impacted short-term profitability.

CVS Health's strategy post-acquisition is focused on integrating Aetna's health insurance business with its existing pharmacy and retail operations to create a more seamless, consumer-centric healthcare experience. The company aims to leverage this integrated model to improve health outcomes and lower overall healthcare costs for its members.

The company's key financial challenges in 2019 included managing the significant debt load acquired with Aetna, continued reimbursement pressure in its retail pharmacy business, and price compression within the Pharmacy Services segment. The company also incurred costs related to store rationalization and the sale of its Brazilian subsidiary.